1976 was full of excitement
In 1974, after reading Dr. Marshall Nirenberg's paper on glioma and neuroblastoma cells (Amano et al., 1972) , I wrote him a letter stating that I wanted to work with him as a post-doctoral fellow. I had previously studied membrane properties and potassium ions in neurons and glia cells in the rabbit cortex (Higashida et al., 1974) . He responded to me in a letter with one sentence stating, "send me recommendation letters". After sending three letters, I patiently waited for his response, but there was none. I then asked Toshiharu Nagatsu, Marshall's friend who worked in the same laboratory (that of Udenfriend) at the National Institutes of Health from 1962 -1964 (Nagatsu et al., 1964 , to ask Marshall about the possibility of me obtaining a postdoctoral position in his laboratory. Then I received a response. Later, I learned that he rarely wrote letters and he only trusted the references of a few people. Nagatsu was one of his trusted friends, and once I met Marshall in 1976, we collaborated together intermittently for 35 years until just before his death on January 15, 2010. I believe that we formed a very personal bond.
In 1976, I started my post-doctoral training in the laboratory of Dr.
Marshall Nirenberg. The first day I met Dr. Nirenberg was Monday, May 4, 1976. I waited for him to come into the laboratory since that morning, but he did not arrive until noon, which was usual at that time. Marshall attended the Monday lunch seminar in the laboratory library, but I did not recognize him. After the seminar, I had a chance to talk to him. When I saw Marshall in his office, which contained many books, journals, experimental notebooks and published articles, The year of 1976 was exciting in the Marshall laboratory because he achieved one of his goals in his neurobiological studies (Table 1) . Ten years prior, he had decided to use neuronal tumor cells as a tool to decipher memory processes in the brain. Cell-cell interaction (recognition) was succeeded by in vitro functional cholinergic synapse formation between neuroblastoma x glioma hybrid cells and two different types of post-synaptic cells: primary muscle cells, which was observed in January (Nelson et al., 1976) , and G-8 clonal muscle cells, which was observed in May (Christian et al., 1976) .
The laboratory was full of excitement and activity. Every postdoctoral fellow waited in front of Marshall's office to discuss their new data that they wanted to publish in the Proceedings of the National Academy of Sciences.
Marshall and each fellow often stayed in the laboratory without sleep on the night before the PNAS deadline each month to complete the final draft of their paper. The laboratory technician would rush to the PNAS office in downtown Washington, DC, to submit the final version of the paper on the day of the deadline. Once, Marshall said to me that submitting a PNAS paper with a limited number of words and printed pages is like writing a "Ha-i-ku", a Japanese poem composed strictly of 17 (5+7+5) Japanese characters.
Initial screening of neuroblastoma cells as presynaptic elements 5
Marshall's aim was to screen presynaptic elements for synapse formation capacity using 21 clonal cells or hybrid cells selected from his huge stock collected at the beginning of experiments (Table 2) In some ways, synapse formation paralleled the ability to synthesize the ACh. However, the parallel was incomplete. Cells with higher synthetic ability formed more synapses, but many other cells with choline acetyltransferase activity did not form synapses (Nirenberg et al, 1983a and b) . It appeared that additional factor(s) controlling ACh release remained undiscovered.
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A clue to the missing factors was obtained 20 years later by researchers in Gif, France. In 1995, when I examined the ACh release capacity of ACh-deficient clones overexpressing choline acetyltransferase, I observed that there were two types of cells: those that can form synapses (ACh release+) and those that cannot (ACh release-) (Zhong et al, 1995a and b) . The representative clones of the former and latter are Neuro2A and N18-TG2 neuroblastoma cells, respectively. In 1996, a French group determined that a 16-kDa proteolipid, a mediatophore in Tordedo electric organs (Israel et al., 1987) , mediates and from NG108-15 cells, and that ATP6V0C mediates dopamine release in the lesioned striatum in hemi-Parkinsonian model mice (Jin et al., 2012, in this issue) , indicating that ATP6V0C is a potential gene therapy agent for
Parkinson's disease. 
Finding the best combination of PGE1 and theophylline for cell differentiation
Marshall did much work to measure adenylyl cyclase activity and intracellular levels of cyclic AMP (cAMP) and cyclic GMP, which were the essential aspects of hormonal signal research at the time (Matsuzawa, 1975; Sharma et al., 1975) even after Gilman left for Charlottesville, Virginia, in early 1970 (Gilman and Nirenberg, 1971) . Marshall reached his favorite working hypothesis for opiate tolerance and dependence by showing the time course of sensitization and desensitization of adenylyl cyclase upon exposure to opiates, resulting in increases and decreases in cAMP content (Sharma et al., 1975) . He in his convertible with his wife, Perola. He would read these papers until late and fall sleep in the early morning. He did not look so strong but rather pale. We were very anxious to know if he suffered from an associated gallbladder tumor, but that was not the case. Due to his life style, whenever he came to Japan, he would say that he could easily adapt to the jet lag because he had lived in the United States on Japanese time.
When we visited him in the hospital after his operation, he smiled when he heard the results regarding PGE1 and theophylline (Nirenberg et al., 1983a and b; Higashida, Wilson, Keninner and Nirenberg, unpublished data).
Screening peptide receptors in NG108-15 cells
In the fall of 1977, Marshall showed me a new idea of his and asked me to try receptor screening in NG108-15 cells using electrophysiology. This method was used to measure membrane potential changes in response to peptides, and it seemed to have advantages over the biochemical assay with each radio-labeled ligand because the electric responses could be obtained in real time 1-2 min after the application of current to cells.
In 1977, A.V. Schally, R. Guillemin, and R.S. Yalow shared the Nobel Prize for identifying and assaying new hormones extracted mammalian tissues.
At that time, it was beginning that peptide hormones were synthesized by a Beckman's peptide synthesis apparatus, and then synthetic hormones had become commercially available. Marshall was attracted to this convenient way of screening for peptide receptors, which were not known in neuroblastoma cells.
He made a list of more than 30 peptides to be tested using Sigma 9 catalog-type experiments. Most of the agents showed no response, with the exception of neurotensin, angiotensin II and bradykinin. Although bradykinin was not included in Marshall's original list, I added it because I was familiar with this pain-inducing peptide in my graduate work in Nagoya, Japan. We concluded that vasoactive peptides induce transient hyperpolarization followed by prolonged depolarization , and no electrical responses were elicited by peptides that preferentially couple to adenylyl cyclase. However, at that time we did not know the mechanism by which these three agents produce such a complex pattern of membrane potential changes. I speculated that such complex sequential changes could be explained by cAMP, but by a different mechanism.
Novel signal transduction via phosphoinositide turnover
Six years later, in 1983, the above question was answered by my own effort with Yano and Nozawa from the Gifu University School of Medicine from which I graduated. Nozawa, a lipid biochemist, was interested in muscarinic ACh receptors (mAChRs), which were expected to couple to phospholipase C because Hokin in Canada (1953) and Michell (1975) and Berridge (2009) (Matsuzawa and Nirenberg, 1975) , we struggled without results for 2-3 months. We then examined bradykinin because I knew that these cells showed electrophysiological responses to this agent. The PI turn over was clearly elevated by bradykinin, and we published this result in the Journal of Biological Chemistry (Yano et al., 1984) . This was the 5 th example of receptor-mediated elevation of PI turnover, and of course the first report of this elevation by bradykinin (Berridge, 1986) .
We later determined why ACh had no effect on PI turnover. When genes for receptors were found and cloned in the 1980s, each receptor consisted of several subtypes, revealing that NG108-15 hybrid cells and other clonal cells express only one receptor subtype, which was a surprise to all of us. NG108-15
and N1E-115 cells possess the m4 subtype of mAChRs , a finding confirmed by me, Fukuda, and Numa at Kyoto University, who obtained numerous genes encoding membrane elements in neurons, such as nicotinic and muscarinic acetylcholine receptors, voltage-dependent sodium and calcium channels, ryanodine receptors and GTP binding proteins Numa, 1987 .
Based on our signal transduction studies, the m1 and m3 subtypes couple to phospholipase C and PI turnover and result in membrane potential changes. However, the m2 and m4 subtypes are selectively coupled to adenylyl cyclase. Therefore, these subtypes do not result in the activation of phospholipase and do not cause membrane changes 
Revolutionary idea of cloning neuronal tumor cells and hybrid cells
Marshall Nirenberg introduced a method for cloning cells commonly used in bacteriology to the study of mammalian neurons after decoding genes.
Studying mammalian neuronal cells with a uniform genetic background was not seriously considered before Marshall's project, and this approach enabled us to characterize biochemical and pharmacological properties and the regulation of neurotransmitters, receptors, ion channels, and intracellular signal transduction.
Thus, Marshall helped to found the new field of neurobiology. This cloning technique has been popular since its inception (Amano et al., 1972 (Minna et al., 1971) and proposed the following differentiation stages from primitive to mature neurons: neurite extrusion (morphological aspect), type B 12 currents (K channel properties), type A currents (sodium channels) and cholinergic properties with choline acetyltransferase. The expression sequence in development can tell us which neuronal properties are the most critical (Minna et al., 1972) . Unfortunately, additional information such as the chromosomal location of these properties was not obtained because most hybrid cells possess tetraploid chromosomes that are a mixture of mice and rats (Kano-Tanaka et al., 1982; Higashida et al., 1985) .
Dopaminergic clone
Another disadvantage of Marshall's clonal cells was that he failed to obtain true dopaminergic cells. He selected adrenergic clones due to tyrosine hydroxylase activity (Amano et al., 1972) because he belonged to one section of the Udenfriend laboratory. Udenfriend, Nagatsu and Perola Zaltmann-Nirenberg (who came from Brazil and spoke Portuguese) characterized tyrosine monooxygenase (hydroxylase) as the first step in tyrosine metabolism to adrenaline (Nagatsu et al., 1964; Udenfriend et al., 1965) . As a result, tyrosine hydroxylase was very familiar to Marshall and Perola. Later, it became clear that these clones lacked the necessary enzymes to make dopamine, noradrenaline and adrenaline. Therefore, these clones were imperfect adrenergic cells.
However, a more suitable PC12 pheochromocytoma clone with dopamine release was introduced by Lloyd Greene, an alumnus of Marshall's laboratory (Greene and Tischler, 1976) . 
Cell-cell recognition by monoclonal antibodies
In 1976, cell-cell interactions were the topic in Marshall's laboratory (Table 1) , because two different cells form a synaptic connection (Nelson et al., 1976) . Usually, heterophilic recognition (e.g., in liver and brain cells) is inhibited to promote aggregation. Synapse formation is a typical means of cell recognition.
Sperry's hypothesis (1963) of the chemical gradient was interesting even to
Marshall (Goolsby et al., 2012, in (Eisenbarth et al., 1979; Trisler et al., 1981; Nirenberg et al., 1983a and b) . show that bradykinin-receptor-induced membrane excitation occurs due to the closure of voltage-dependent time-independent potassium M-currents (Higashida and Brown, 1986) . Thereafter, we worked together on the mechanism of IP3 and protein kinase C, and we proposed that these secondary messengers are responsible for biphasic membrane currents (Brown and Higashida 1988) . Later, this hypothesis was applied to mACh receptors .
Bradykinin receptor signaling
Using pertussis toxin, I, Klee and Nirenberg suggested that bradykinin receptors use the Gi or Go GTP binding proteins to couple to phospholipase C in signal transduction . Unfortunately, this suggestion later turned out to be not completely correct (Taussing et al., 1992) , although bradykinin receptors were determined to couple to pertussis toxin-sensitive G proteins. Pertussis toxin-insensitive Gq/11 G proteins were not known at that time, which could be one reason that this suggestion may have been incorrect (Smrcka et el., 1991; Taylor et al., 1991) . However, our work stimulated a field of research on the links between signaling molecules and membrane currents.
The best image of a real scientist
Around 1985, Marshall tried to clone genes for Gαs proteins and Gαi G proteins (Bray et al., 1986 and 1987) . He read amino acid sequences by 16 translating nucleotide sequences using a genetic code table. I frequently saw
him through the open door of his room trying to do this. At that time, every researcher manually translated each triplet to an amino acid using this table.
Every researcher in the molecular and biochemical fields owes him for this discovery, and he also used his code table in his gene cloning research. I thought to myself, "This is science!"
At that time, Marshall tried to clone bradykinin receptors. As a first step, he proposed to purify bradykinin receptors using [S 35 ]GTP-γ-S as a probe. He thought bradykinin receptors expressed in NG108-15 cells could be pulled down as radiolabeled GTP, G protein and bradykinin receptor complexes that could be trapped in filters (Figure 1) , which is one of his favorite methods. Then, we could make a bradykinin receptor antibody or determine a partial bradykinin receptor amino acid sequence for gene cloning. He proposed that [Ca 45 ] release from HEK cells expressing bradykinin receptors from the transfection of candidate cDNAs could be used for characterization in multi-well plates. Unfortunately, the postdoctoral fellow from Japan who used this functional gene cloning method was not successful. However, a similar functional cloning strategy was successfully applied to capsaicin-receptor ion channels (Caterina et al., 1997) .
Genome-wide screening for synapse-forming genes in fruit flies
The last project I worked on with Marshall was genome-wide screening for genes related to heart and neuron development using RNA interference (Ivanov et al., 2004; Koizumi et al., 2007) . Marshall applied for a special grant from the National Heart, Lung, and Blood Institute and received money to initiate genome-wide research in Drosophila embryos 2 years later than the discovery of RNAi by Fire and Mello (Fire et al., 1998) He also moved to his old location on the 7 th floor in corridor D of Building 10, the main NIH building. I heard that he had moved to the same location in which he had conducted research on the genetic code. He used half of a room for his own office at his request. He didn't feel he needed all the space he had to do his work and didn't want to see it wasted when other scientists might be able to use it. He was quite content to have a small office. His new laboratory was downsized to one-third the size of his old laboratory in Building 36, where he used two floors (received after being awarded the Nobel price) and kept all kinds of supplies and constantly refilled chemicals. The liquid nitrogen for keeping culture cells was maintained by two technicians, and 4-5 secretaries were always in his office.
New studies on social memory and autism
In 2003, I published an article on the mechanism by which Kv7.2 (M-type) potassium channels are closed by protein kinase C and the A-kinase anchoring protein in response to ACh (Hoshi et al., 2003) . Based on this publication and suggestions for faculty development by Marshall and Myrna, I
was awarded a sizable grant from the central government at the Kanazawa University Center of Excellence Program on Innovative Brain Science on Learning, Memory and Development. In this program, I focused on social cognition, memory and autism spectrum disorders. When I examined male behavior in CD38 knockout mice, males showed impaired social memory in the form of amnesia regarding mates from previous encounters (Jin et al., 2007; . Two single nucleotide polymorphisms in human CD38
were determined to be associated with autism spectrum disorder (Munesue et al., 2010) .
Additionally, I further characterized two genes, Robo and Pebble, which were identified as strong candidates for involvement in synapse formation in Drosophila embryos by the RNAi whole-genome project (Ivanov et al., 2003; Koizumi et al., 2007) . Expression of the axon guidance receptors ROBO1 and ROBO2 was significantly reduced in the lymphocytes of an autistic group (Anitha et al., 2008) and in the anterior cingulate cortex and primary motor cortex of postmortem brains of autistic humans (Suda et al., 2011) . My daughter, who met Marshall frequently from 3 to 5 years of age at the NIH kindergarten, and I
showed that the Rho guanine nucleotide exchange factor Ect2, an ortholog of Drosophila Pebble, negatively regulates neurite outgrowth in neuroblastoma × glioma hybrid NG108-15 cells, and that this protein is expressed in the 20 developing mouse pituitary gland (Islam et al., 2010; Tsuji et al., 2011) isotopes of sulfide and calcium as tracers.
